| Literature DB >> 12847168 |
Antonella Afeltra1, Pierluigi Garzia, Anna Paola Mitterhofer, Marta Vadacca, Sara Galluzzo, Flavia Del Porto, Licia Finamore, Stefano Pascucci, Marina Gasparini, Bruno Laganà, Domenico Caccavo, Giovanni Maria Ferri, Antonio Amoroso, Ada Francia.
Abstract
The authors assessed the prevalence of neuropsychiatric manifestations occurring in patients with systemic lupus erythematosus (NPSLE), according to the American College of Rheumatology standardized definitions for NPSLE, and evaluated the relationship between NPSLE and antiphospholipid antibodies. Sixty-one consecutive SLE patients were studied. Neuropsychiatric manifestations consistent with the diagnosis of NPSLE occurred in 44 (72%). Patients with NPSLE showed significantly higher levels of anticardiolipin antibodies.Entities:
Mesh：
Substances：
Year: 2003 PMID： 12847168 DOI： 10.1212/01.wnl.0000058904.94330.a7
Source DB: PubMed Journal: Neurology ISSN： 0028-3878 Impact factor: 9.910